AT1 0.00% 2.2¢ atomo diagnostics limited

Atomo COVID device is clinically validated in France and has the...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 756 Posts.
    lightbulb Created with Sketch. 392
    Atomo COVID device is clinically validated in France and has the CE mark in Europe. I have no doubt that TGA will approve the device for use in Aus. TGA taking such a long time to approve is a mystery to me as AT1 seem to have submitted in March - unless Atomo has also asked for self testing approval.

    This is the first price sensitive announcement by AT1 since the listing. This seems substantial price sensitive announcement - why ASX taking time to release it.

    https://www.bioworld.com/articles/434881-roche-discusses-launch-of-newly-approved-serology-test-to-detect-covid-19

    https://hotcopper.com.au/data/attachments/2142/2142149-61c18c5bd3e963c3fdd889a89f68459a.jpg
    https://hotcopper.com.au/data/attachments/2142/2142151-09162c39bc5686cea4c020550fc4fae8.jpg
    GLTAH
 
watchlist Created with Sketch. Add AT1 (ASX) to my watchlist
(20min delay)
Last
2.2¢
Change
0.000(0.00%)
Mkt cap ! $14.06M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
2 206074 2.2¢
 

Sellers (Offers)

Price($) Vol. No.
2.3¢ 38000 1
View Market Depth
Last trade - 07.00am 01/11/2024 (20 minute delay) ?
AT1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.